[go: up one dir, main page]

CN103652891A - Lactobacillus casei embedding microcapsule and preparation method thereof - Google Patents

Lactobacillus casei embedding microcapsule and preparation method thereof Download PDF

Info

Publication number
CN103652891A
CN103652891A CN201310626099.1A CN201310626099A CN103652891A CN 103652891 A CN103652891 A CN 103652891A CN 201310626099 A CN201310626099 A CN 201310626099A CN 103652891 A CN103652891 A CN 103652891A
Authority
CN
China
Prior art keywords
lactobacillus casei
microcore
microcapsule
core
palm oil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201310626099.1A
Other languages
Chinese (zh)
Other versions
CN103652891B (en
Inventor
柳永
汤江武
王新
孙宏
姚晓红
吴逸飞
周曼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhejiang Academy of Agricultural Sciences
Original Assignee
Zhejiang Academy of Agricultural Sciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhejiang Academy of Agricultural Sciences filed Critical Zhejiang Academy of Agricultural Sciences
Priority to CN201310626099.1A priority Critical patent/CN103652891B/en
Publication of CN103652891A publication Critical patent/CN103652891A/en
Application granted granted Critical
Publication of CN103652891B publication Critical patent/CN103652891B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23PSHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00Shaping or working of foodstuffs characterised by the products
    • A23P10/30Encapsulation of particles, e.g. foodstuff additives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K10/00Animal feeding-stuffs
    • A23K10/10Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00Lactic or propionic acid bacteria
    • A23V2400/11Lactobacillus
    • A23V2400/125Casei

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

本发明提供一种包埋干酪乳杆菌的微胶囊,其特征在于:微胶囊为三层包埋的多芯结构,其中,干酪乳杆菌被包埋于第一个水凝胶包被层中形成微芯,在所述的微芯外的第二个包被层为植物油,多个携带植物油包被的微芯被包埋于由水溶性高分子材料形成的第三个包被层中,形成多芯微胶囊。该微胶囊在干燥加工和储藏过程中,能够显著提高干酪乳杆菌的存活率,表现出优良的干酪乳杆菌活菌保藏性能,在食品、医药以及饲料领域具有良好的应用潜力。The invention provides a microcapsule for embedding Lactobacillus casei, which is characterized in that: the microcapsule is a three-layer embedded multi-core structure, wherein Lactobacillus casei is embedded in the first hydrogel coating layer to form The microcore, the second coating layer outside the microcore is vegetable oil, and a plurality of microcores coated with vegetable oil are embedded in the third coating layer formed by water-soluble polymer materials, forming multi-core microcapsules. The microcapsule can significantly improve the survival rate of Lactobacillus casei during drying processing and storage, exhibits excellent preservation performance of live Lactobacillus casei, and has good application potential in the fields of food, medicine and feed.

Description

一种包埋干酪乳杆菌的微胶囊及其制备方法A kind of microcapsule of embedding Lactobacillus casei and preparation method thereof

  the

技术领域:Technical field:

本发明涉及的是一种微生物包埋技术,具体涉及的是三大益生菌之一的干酪乳杆菌的多芯微胶囊化包埋技术。 The invention relates to a microorganism embedding technology, in particular to the multi-core microencapsulation embedding technology of Lactobacillus casei, one of the three major probiotics.

背景技术:Background technique:

干酪乳杆菌(Lactobacillus casei)是一种益生菌,能够进入人体后在肠道内大量存活,起到调节肠内菌群平衡、促进人体消化吸收等作用,同时具有高效降血压、降胆固醇,增强人体免疫及预防癌症和抑制肿瘤生长等功能,在食品医药及饲料领域有很好的应用潜力。但是收微胶囊干燥过程中的渗透压增高,以及储存过程中的氧胁迫等因素的影响,干酪乳杆菌极易死亡,需要针对干酪乳杆菌对渗透压敏感和不耐氧胁迫的生理特点,建立阻氧和菌体周围渗透压稳定的微囊化包埋体系,以提高干酪乳杆菌的应用性能。 Lactobacillus casei (Lactobacillus casei) is a kind of probiotics, which can survive in large quantities in the intestinal tract after entering the human body, regulate the balance of intestinal flora, promote digestion and absorption of the human body, etc. Functions such as immunity, cancer prevention and tumor growth inhibition have good application potential in the fields of food, medicine and feed. However, due to the increase of osmotic pressure during the drying process of microcapsules and the influence of factors such as oxygen stress during storage, Lactobacillus casei is very easy to die. A microencapsulated embedding system with oxygen resistance and stable osmotic pressure around the bacteria to improve the application performance of Lactobacillus casei.

经过对现有技术的检索发现,针对干酪乳杆菌类益生菌的微囊化包埋方法和包埋产物,均具有提高益生菌抗逆性的效果。微胶囊的包埋壁材和辅料以海藻酸钠、明胶、羟甲基纤维素、β-环糊精、多孔淀粉、果胶、阿拉伯胶和益生元等为主;胶囊结构类型多为单芯-固芯微胶囊,少数为单芯-液芯微胶囊;部分微胶囊两层或多层包埋,但均为单芯微胶囊,且最外层包埋为油脂或卵磷脂类,  After searching the prior art, it is found that the microencapsulation embedding method and embedding products for probiotics of Lactobacillus casei have the effect of improving the stress resistance of probiotics. The embedding wall materials and excipients of microcapsules are mainly sodium alginate, gelatin, hydroxymethyl cellulose, β-cyclodextrin, porous starch, pectin, acacia gum and prebiotics; the capsule structure type is mostly single core -Solid-core microcapsules, a few are single-core-liquid-core microcapsules; some microcapsules are embedded in two or more layers, but all are single-core microcapsules, and the outermost layer is embedded with oil or lecithin,

发明内容。Invention content.

本发明针对干酪乳杆菌不耐氧胁迫和渗透压变化,微囊化包埋和储存过程易死亡的问题,提供一种高活性干酪乳杆菌微囊化包埋方法,有效提高干酪乳杆菌耐热性和储藏性能。 The present invention aims at the problem that Lactobacillus casei is not resistant to oxygen stress and osmotic pressure changes, and is prone to death during microencapsulation embedding and storage, and provides a microencapsulation embedding method with high activity Lactobacillus casei, which can effectively improve the heat resistance of Lactobacillus casei properties and storage properties.

本发明微胶囊为多芯结构,棕榈油脂肪层为中间包被层,以及最外层微胶囊壁材为碳酸钙、海藻酸钠和黄原胶混合物等特征均。 The microcapsule of the present invention has a multi-core structure, the palm oil fat layer is the middle coating layer, and the outermost microcapsule wall material is a mixture of calcium carbonate, sodium alginate and xanthan gum.

 一方面,本发明提供一种包埋酪乳杆菌的微胶囊,其特征在于:微胶囊为三层包埋的多芯结构,其中,干酪乳杆菌菌泥或固态发酵产物被包埋于第一水凝胶包被层中形成微芯,在所述的微芯外的第二个包被层为植物油,多个携带植物油包被的微芯被包埋于由水溶性高分子材料形成的第三个包被层中,其中,所述的干酪乳杆菌菌泥或固态发酵产物为保藏号为CCTCC NO:M 2011424的干酪乳杆菌菌株BFT-1所产生。 On the one hand, the present invention provides a microcapsule for embedding Lactobacillus casei, which is characterized in that: the microcapsule is a three-layer embedded multi-core structure, wherein the Lactobacillus casei sludge or solid-state fermentation product is embedded in the first A microcore is formed in the hydrogel coating layer, and the second coating layer outside the microcore is vegetable oil, and a plurality of microcores coated with vegetable oil are embedded in the first water-soluble polymer material. Among the three coating layers, the said Lactobacillus casei sludge or solid-state fermentation product is produced by the Lactobacillus casei strain BFT-1 whose preservation number is CCTCC NO: M 2011424.

优选的,所述的干酪乳杆菌浓度为109~1011cfu/ml。优选的,所述的微芯结构为水凝胶,粒径10~100μm,第二包被层包为融点为24℃的棕榈油层。 Preferably, the concentration of Lactobacillus casei is 10 9 -10 11 cfu/ml. Preferably, the microcore structure is a hydrogel with a particle size of 10-100 μm, and the second coating layer is wrapped with a palm oil layer with a melting point of 24°C.

优选的,本发明设涉及包埋干酪乳杆菌的多芯微胶囊包括:干酪乳杆菌、卡拉胶、斯潘-80、棕榈油、碳酸钙、海藻酸钠和黄原胶,其中:干酪乳杆菌包埋于卡拉胶、葡萄糖、酵母抽提物和乳酸形成的水凝胶微芯中,该微芯进一步包埋于斯潘-80和棕榈油混合物中形成乳浊液,该乳浊液进一步分散于碳酸钙、海藻酸钠和黄原胶混合溶液中,并滴入固化液中形成固化多芯微胶囊。 Preferably, the present invention relates to multi-core microcapsules for embedding Lactobacillus casei including: Lactobacillus casei, carrageenan, Span-80, palm oil, calcium carbonate, sodium alginate and xanthan gum, wherein: Lactobacillus casei Embedded in hydrogel microcores of carrageenan, dextrose, yeast extract, and lactic acid, which are further embedded in a mixture of Span-80 and palm oil to form an emulsion, which is further dispersed In the mixed solution of calcium carbonate, sodium alginate and xanthan gum, and drop into the solidification solution to form solidified multi-core microcapsules.

所述的干酪乳杆菌微芯的粒径分布为10~100μm,所述多芯微胶囊的粒径分布为0.5~5mm。 The particle size distribution of the Lactobacillus casei micro-core is 10-100 μm, and the particle size distribution of the multi-core microcapsule is 0.5-5 mm.

多芯微胶囊中,干酪乳杆菌的包封率为:70~99%。 In the multi-core microcapsules, the encapsulation rate of Lactobacillus casei is 70-99%.

另一方面,本发明涉及上述包埋干酪乳杆菌的多芯微胶囊的制备方法,包括以下步骤: On the other hand, the present invention relates to the preparation method of the above-mentioned multi-core microcapsules of Lactobacillus casei embedded, comprising the following steps:

第一步,制备干酪乳杆菌水凝胶溶液:配制pH为3.5~5.0、卡拉胶质量百分含量为0.1~2%、葡萄糖含量0.1~0.5%、酵母抽提物含量为0.1~0.5%、乳酸浓度为1~5%的混合水溶液,并将温度调节到38~45℃。然后加入干酪乳杆菌菌泥或固态发酵产物,即形成干酪乳杆菌水凝胶溶液。优选的,最合适的温度为40℃,干酪乳杆菌的最佳浓度是8×1010cfu/mL。 The first step is to prepare Lactobacillus casei hydrogel solution: the preparation pH is 3.5-5.0, the mass percentage of carrageenan is 0.1-2%, the content of glucose is 0.1-0.5%, the content of yeast extract is 0.1-0.5%, Lactic acid concentration is 1~5% mixed aqueous solution, and the temperature is adjusted to 38~45°C. Then add Lactobacillus casei sludge or solid-state fermentation product to form Lactobacillus casei hydrogel solution. Preferably, the most suitable temperature is 40°C, and the optimum concentration of Lactobacillus casei is 8×10 10 cfu/mL.

第二步, 制备外层棕榈油包被的干酪乳杆菌水凝胶微芯:将第一步所述干酪乳杆菌水凝胶溶液按体积比1:1~5(最佳的比例为1:3)与相同温度的棕榈油混合,其中棕榈油中包括质量百分比浓度为1~5%的斯潘-80,在1000~2000转/分钟搅拌下形成乳液,然后冷却到25℃,即可形成外层棕榈油包被的干酪乳杆菌水凝胶微芯,结构特征为固态凝胶微芯。 The second step is to prepare the Lactobacillus casei hydrogel microcore coated with palm oil in the outer layer: the Lactobacillus casei hydrogel solution described in the first step is in a volume ratio of 1:1 to 5 (the best ratio is 1: 3) Mix with palm oil at the same temperature, wherein the palm oil includes Span-80 with a mass percentage concentration of 1-5%, form an emulsion under stirring at 1000-2000 rpm, and then cool to 25°C to form The Lactobacillus casei hydrogel microcore coated with palm oil has a structural feature of a solid gel microcore.

第三步,制备包埋干酪乳杆菌微芯的多芯微胶囊:将第二步所述外层棕榈油包被的干酪乳杆菌微芯乳液按体积比1:2~4(最佳的比例为1:3)与碳酸钙-海藻酸钠-黄原胶混合溶液混合均匀(海藻酸钠和黄原胶的质量比为20:1~5、合计质量百分比浓度为1~3%,碳酸钙质量百分比含量为0.5~3%,温度为22~26℃),并滴入温度为0~20℃的1~4%氯化钙溶液中,半小时后形成包埋干酪乳杆菌微芯的固化多芯微胶囊,该胶囊中干酪乳杆菌微芯、棕榈油和海藻酸钠等均为固态结构。 The third step is to prepare multi-core microcapsules embedded with Lactobacillus casei micro-core: the Lactobacillus casei micro-core emulsion coated with the outer palm oil described in the second step is in a volume ratio of 1:2~4 (optimum ratio 1:3) mixed with calcium carbonate-sodium alginate-xanthan gum mixed solution (the mass ratio of sodium alginate and xanthan gum is 20:1~5, the total mass percentage concentration is 1~3%, calcium carbonate The mass percentage content is 0.5~3%, the temperature is 22~26°C), and it is dropped into the 1~4% calcium chloride solution at the temperature of 0~20°C, and after half an hour, the solidification of embedded Lactobacillus casei microcores is formed. Multi-core microcapsules, in which Lactobacillus casei microcores, palm oil and sodium alginate are all solid structures.

本发明所有的百分比含量,没有特备指明,都属于质量百分比含量。 All percentages in the present invention, unless otherwise specified, belong to mass percentages.

本发明通过调节卡拉胶、斯潘-80、碳酸钙、棕榈油、海藻酸钠和黄原胶的浓度和比例来调节干酪乳杆菌微芯的粒径分布、干酪乳杆菌的包封率、干酪乳杆菌存活率以及成品多芯微胶囊的粒径分布,以满足多种应用需求。例如,通过升高卡拉胶的浓度可获得粒径较大的干酪乳杆菌微芯,反之获得粒径较小的微芯,卡拉胶浓度与微芯粒径呈负相关关系;通过提高棕榈油与干酪乳杆菌水凝胶溶液的体积比可得到较高干酪乳杆菌包封率,反之包封率降低,棕榈油与干酪乳杆菌水凝胶体积比与包封率呈负相关关系;通过调整挤出孔径大小可以调节最终多芯微胶囊尺寸,挤出孔径越小粒径越小,挤出孔径越大粒径越大,挤出孔径大小与多芯微胶囊大小呈正相关。 The present invention adjusts the particle size distribution of the Lactobacillus casei microcore, the encapsulation efficiency of the Lactobacillus casei, and the Lactobacillus survival rate and particle size distribution of finished multi-core microcapsules to meet various application requirements. For example, by increasing the concentration of carrageenan, Lactobacillus casei microcores with larger particle sizes can be obtained, and vice versa, microcores with smaller particle sizes are obtained, and the concentration of carrageenan is negatively correlated with the particle size of microcores; The volume ratio of Lactobacillus casei hydrogel solution can obtain higher encapsulation efficiency of Lactobacillus casei, otherwise the encapsulation efficiency decreases, and the volume ratio of palm oil and Lactobacillus casei hydrogel has a negative correlation with the encapsulation efficiency; The size of the exit pore can adjust the size of the final multi-core microcapsule. The smaller the extrusion pore size, the smaller the particle size, and the larger the extrusion pore size, the larger the particle size. The extrusion pore size is positively correlated with the size of the multi-core microcapsule.

本发明所制备包埋干酪乳杆菌的多芯微胶囊中干酪乳杆菌含量为109~1011cfu/ mL,在85℃下加热处理3分钟,剩余活菌数107~1010cfu/ mL;25℃下密封储存60天,剩余活菌数108~1010cfu/ mL;人工模拟胃液下4小时,干酪乳杆菌释放量不高于20%;人工模拟肠液下4小时,干酪乳杆菌释放量不低于90%。与传统产品相比,耐热性和储存性能提高显著,过胃肠溶性能优异。 The content of Lactobacillus casei in the multi-core microcapsules embedded with Lactobacillus casei prepared by the present invention is 10 9 to 10 11 cfu/mL, and after heat treatment at 85°C for 3 minutes, the number of remaining viable bacteria is 10 7 to 10 10 cfu/mL ; Sealed storage at 25°C for 60 days, the number of remaining viable bacteria is 10 8 ~ 10 10 cfu/mL; 4 hours in artificially simulated gastric juice, the release of Lactobacillus casei is not higher than 20%; 4 hours in artificially simulated intestinal juice, Lactobacillus casei The release amount is not less than 90%. Compared with traditional products, the heat resistance and storage performance are significantly improved, and the performance of gastrointestinal dissolution is excellent.

有益效果Beneficial effect

本发明制备操作简单,所得微胶囊无粘连,成球性好,表面圆整,在人工模拟胃液下释放缓慢释放量较低,在人工模拟肠液下可快速大量释放干酪乳杆菌,有利于干酪乳杆菌在动物肠道中的定点释放和发挥功效。 The preparation and operation of the present invention are simple, and the obtained microcapsules have no adhesion, good spheroidity, rounded surface, slow release under artificially simulated gastric juice, and low release amount, and can quickly and massively release Lactobacillus casei under artificially simulated intestinal juice, which is beneficial to cheese milk Targeted release and efficacy of bacilli in the animal gut.

附图说明 Description of drawings

图1为微胶囊外观和内部微芯结构照片图,其中。A、B、C和D顺次为实施例1、2、3和4的微胶囊外观和内部微芯结构照片(上排为外观,下排为对应的内部结构)。 Fig. 1 is a microcapsule appearance and a photogram of the internal microcore structure, wherein. A, B, C and D are photos of the microcapsule appearance and internal microcore structure of Examples 1, 2, 3 and 4 in sequence (the upper row is the appearance, and the lower row is the corresponding internal structure).

干酪乳杆菌BFT-1,分类命名:干酪乳杆菌BFT-1,拉丁学名:Lactobacillus casei BFT-1,保藏号:CCTCC NO:M 2011424,保藏日期为2011年11月25日,保藏单位为:中国典型培养物保藏中心,地址:中国.武汉.武汉大学,邮编:430072。 Lactobacillus casei BFT-1, classification name: Lactobacillus casei BFT-1, Latin scientific name: Lactobacillus casei BFT-1, preservation number: CCTCC NO: M 2011424, preservation date is November 25, 2011, preservation unit is: China Typical Culture Collection Center, address: Wuhan University, Wuhan, China, zip code: 430072.

具体实施方式 Detailed ways

下面对本发明的实施例作详细说明,本实施例在以本发明技术方案为前提下进行实施,给出了详细的实施方式和具体的操作过程,但本发明的保护范围不限于下述的实施例。 The embodiments of the present invention are described in detail below. This embodiment is implemented on the premise of the technical solution of the present invention, and detailed implementation methods and specific operating procedures are provided, but the protection scope of the present invention is not limited to the following implementation example.

以下实施例的涉及包埋干酪乳杆菌的多芯微胶囊包括:干酪乳杆菌BFT-1 (Lactobacillus casei BFT-1 )(保藏号:CCTCC NO:M2011424,保藏日期为2011年11月25日,保藏单位为中国典型培养物保藏中心,地址:中国.武汉.武汉大学)、干酪乳杆菌水凝胶微芯、棕榈油、海藻酸钠和黄原胶微胶囊壁,其中:干酪乳杆菌包埋于水凝胶微芯中,并进一步依次被棕榈油和海藻酸钠-黄原胶包被于外部,最终形成包埋干酪乳杆菌的多芯微胶囊。 The multi-core microcapsules related to embedding Lactobacillus casei of the following examples include: Lactobacillus casei BFT-1 ( Lactobacillus casei BFT-1) (preservation number: CCTCC NO: M2011424, preservation date is November 25, 2011, preservation The unit is China Typical Culture Collection Center, address: China. Wuhan. Wuhan University), Lactobacillus casei hydrogel micro-core, palm oil, sodium alginate and xanthan gum microcapsule wall, in which: Lactobacillus casei is embedded in The hydrogel micro-core is further coated on the outside by palm oil and sodium alginate-xanthan gum in turn, finally forming a multi-core microcapsule embedding Lactobacillus casei.

在下列所有实施例子中的干酪乳杆菌菌泥或干酪乳杆菌固态发酵物料由保藏号为CCTCC No:M2011424的干酪乳杆菌菌株BFT-1所产生。 The Lactobacillus casei sludge or the Lactobacillus casei solid-state fermentation material in all the following examples is produced by the Lactobacillus casei strain BFT-1 with the preservation number of CCTCC No: M2011424.

实施例1Example 1

步骤1:将0.1g卡拉胶悬浮于100mL蒸馏水中,加热溶解后加入0.1g葡萄糖、0.1g酵母抽提物和1.0g乳酸,以氢氧化钠调节pH为3.5,并冷却到38℃。 Step 1: Suspend 0.1g of carrageenan in 100mL of distilled water, heat to dissolve, add 0.1g of glucose, 0.1g of yeast extract and 1.0g of lactic acid, adjust the pH to 3.5 with sodium hydroxide, and cool to 38°C.

步骤2:然后在步骤1形成的溶液中加入干酪乳杆菌菌泥或干酪乳杆菌固态发酵物料,并混合均匀(混合液中干酪乳杆菌浓度为6.3×109cfu/mL)。 Step 2: Then add Lactobacillus casei sludge or Lactobacillus casei solid-state fermentation material to the solution formed in Step 1, and mix evenly (the concentration of Lactobacillus casei in the mixed solution is 6.3×10 9 cfu/mL).

步骤3:将步骤2获得的上述混合溶液与100mL温度为38℃的棕榈油混合,其中棕榈油中包括质量百分比含量为1%的斯潘-80,并在1000转/分钟搅拌速度下搅拌至温度下降到25℃时继续搅拌30min,此时即获得干酪乳杆菌水凝胶微芯乳液,微芯的平均粒径为93.2μm。 Step 3: Mix the above mixed solution obtained in step 2 with 100mL of palm oil at a temperature of 38°C, wherein the palm oil includes 1% Span-80 by mass percentage, and stir at a stirring speed of 1000 rpm to When the temperature dropped to 25° C., the stirring was continued for 30 minutes, at which point the Lactobacillus casei hydrogel micro-core emulsion was obtained, and the average particle diameter of the micro-core was 93.2 μm.

步骤4:进一步将步骤3形成的上述200mL微芯乳液与400mL碳酸钙、海藻酸钠和黄原胶溶液混合均匀(海藻酸钠与黄原胶质量比为20:1、合计质量百分比浓度为1%,碳酸钙质量百分比为0.5%,温度为22℃),然后,挤出到温度为0℃的1%氯化钙溶液中,形成粒径约0.5mm的固化多芯微胶囊(图1,A)。 Step 4: Further mix the above-mentioned 200mL microcore emulsion formed in step 3 with 400mL calcium carbonate, sodium alginate and xanthan gum solution (the mass ratio of sodium alginate to xanthan gum is 20:1, and the total mass percentage concentration is 1 %, the mass percentage of calcium carbonate is 0.5%, and the temperature is 22°C), and then extruded into a 1% calcium chloride solution at 0°C to form solidified multi-core microcapsules with a particle size of about 0.5mm (Figure 1, A).

该微胶囊无粘连、成球性好、表面圆整,干酪乳杆菌菌数为1×109cfu/mL,包封率为71.3%;在85℃下加热处理3分钟,剩余活菌数为2.5×107cfu/mL,未包埋干酪乳杆菌菌泥或固态发酵物料在1000倍稀释下,未检测到活菌;在25℃下密封储存60天,剩余活菌数为4.1×108cfu/mL;在人工模拟胃液下4小时,干酪乳杆菌释放量为19.8%,人工模拟肠液下4小时,干酪乳杆菌释放量为95.7%。 The microcapsules have no adhesion, good spheroidity, and rounded surface. The number of Lactobacillus casei is 1×10 9 cfu/mL, and the encapsulation efficiency is 71.3%. After heat treatment at 85°C for 3 minutes, the number of remaining viable bacteria is 2.5×10 7 cfu/mL, unembedded Lactobacillus casei sludge or solid-state fermentation material was diluted 1000 times, no viable bacteria were detected; when stored in a sealed container at 25°C for 60 days, the remaining viable bacteria were 4.1×10 8 cfu/mL; 4 hours under artificial simulated gastric juice, the release amount of Lactobacillus casei was 19.8%, and under artificial simulated intestinal juice for 4 hours, the release amount of Lactobacillus casei was 95.7%.

实施例2Example 2

步骤1:将2g卡拉胶悬浮于100mL蒸馏水中,加热溶解后加入0.5g葡萄糖、0.5g酵母抽提物和5.0g乳酸,以氢氧化钠调节pH为5.0,并冷却到45℃。 Step 1: Suspend 2g of carrageenan in 100mL of distilled water, heat to dissolve, add 0.5g of glucose, 0.5g of yeast extract and 5.0g of lactic acid, adjust the pH to 5.0 with sodium hydroxide, and cool to 45°C.

步骤2:在步骤1形成的溶液中加入干酪乳杆菌菌泥或干酪乳杆菌固态发酵物料,并混合均匀(混合液中干酪乳杆菌浓为3.5×1012cfu/mL)。 Step 2: Add Lactobacillus casei sludge or Lactobacillus casei solid-state fermentation material to the solution formed in Step 1, and mix evenly (the concentration of Lactobacillus casei in the mixed solution is 3.5×10 12 cfu/mL).

步骤3:将步骤2中形成的上述混合溶液与500mL温度为45℃的棕榈油混合,其中棕榈油中包括质量百分比含量为5%的斯潘-80,并在2000转/分钟搅拌速度下搅拌至温度下降到35℃时继续搅拌30分钟,此时即获得干酪乳杆菌水凝胶微芯乳液,微芯的平均粒径为10.4μm。 Step 3: Mix the above mixed solution formed in step 2 with 500mL of palm oil at a temperature of 45°C, wherein the palm oil includes 5% Span-80 by mass percentage, and stir at a stirring speed of 2000 rpm Stirring was continued for 30 minutes until the temperature dropped to 35° C., at which point a Lactobacillus casei hydrogel micro-core emulsion was obtained, and the average particle diameter of the micro-core was 10.4 μm.

步骤4:进一步将步骤3形成的上述600mL微芯乳液与2400mL碳酸钙、海藻酸钠和黄原胶溶液混合均匀(海藻酸钠与黄原胶质量比为20:5、合计质量百分比浓度为3%,碳酸钙质量百分比浓度为3%,温度为26℃),并挤出到温度为20℃的4%氯化钙溶液中,形成粒径约5mm的固化多芯微胶囊(图1,B)。 Step 4: Further mix the above-mentioned 600mL microcore emulsion formed in step 3 with 2400mL calcium carbonate, sodium alginate and xanthan gum solution (the mass ratio of sodium alginate to xanthan gum is 20:5, and the total mass percentage concentration is 3 %, the mass percentage of calcium carbonate is 3%, the temperature is 26°C), and extruded into a 4% calcium chloride solution at a temperature of 20°C to form solidified multi-core microcapsules with a particle size of about 5 mm (Fig. 1, B ).

该微胶囊无粘连、成球性好、表面圆整,干酪乳杆菌菌数为1×1011cfu/mL,包封率为99.1%;在85℃下加热处理3分钟,剩余活菌数为1.2×1010cfu/mL;在25℃下密封储存60天,剩余活菌数为4.8×1010cfu/mL;在人工模拟胃液下4小时,干酪乳杆菌释放量为12.5%,人工模拟肠液下4小时,干酪乳杆菌释放量为90.5%。 The microcapsules have no adhesion, good spheroidity, and rounded surface. The number of Lactobacillus casei is 1×10 11 cfu/mL, and the encapsulation efficiency is 99.1%. After heat treatment at 85°C for 3 minutes, the number of remaining viable bacteria is 1.2×10 10 cfu/mL; sealed storage at 25°C for 60 days, the number of remaining viable bacteria is 4.8×10 10 cfu/mL; 4 hours under artificial simulated gastric juice, the release of Lactobacillus casei is 12.5%, artificial simulated intestinal juice After 4 hours, the release amount of Lactobacillus casei was 90.5%.

实施例3Example 3

步骤1:将1g卡拉胶悬浮于100mL蒸馏水中,加热溶解后加入0.25g葡萄糖和0.25g酵母抽提物和2.5g乳酸,以氢氧化钠调节pH为4.2,并冷却到41.5℃。 Step 1: Suspend 1g of carrageenan in 100mL of distilled water, heat to dissolve, add 0.25g of glucose, 0.25g of yeast extract and 2.5g of lactic acid, adjust the pH to 4.2 with sodium hydroxide, and cool to 41.5°C.

步骤2:然后在步骤1形成的溶液中加入干酪乳杆菌菌泥或干酪乳杆菌固态发酵物料,并混合均匀(混合液中干酪乳杆菌浓度为1.5×1011cfu/mL)。 Step 2: Then add Lactobacillus casei sludge or Lactobacillus casei solid-state fermentation material to the solution formed in step 1, and mix evenly (the concentration of Lactobacillus casei in the mixed solution is 1.5×10 11 cfu/mL).

步骤3:将上述混合溶液与250mL温度为41.5℃的棕榈油混合,其中棕榈油中包括质量百分比含量为2.5%的斯潘-80,并在1500转/分钟搅拌速度下搅拌至温度下降到25℃时继续搅拌30分钟,此时即获得干酪乳杆菌水凝胶微芯乳液,微芯的平均粒径为53.8μm。 Step 3: Mix the above mixed solution with 250mL of palm oil at a temperature of 41.5°C, wherein the palm oil includes 2.5% Span-80 by mass percentage, and stir at a stirring speed of 1500 rpm until the temperature drops to 25 Stirring was continued for 30 minutes at a temperature of 0° C., at which point a Lactobacillus casei hydrogel micro-core emulsion was obtained, and the average particle diameter of the micro-core was 53.8 μm.

步骤4:进一步将步骤3形成的上述350mL微芯乳液与1050mL碳酸钙、海藻酸钠和卡拉胶溶液混合均匀(海藻酸钠与卡拉胶质量比为20:3、合计质量百分比浓度为3%,碳酸钙质量百分比含量为2%,温度为23℃),并挤出到温度为10℃的2.5%氯化钙溶液中,形成粒径约3mm的固化多芯微胶囊(图1,C)。 Step 4: further mix the above-mentioned 350mL microcore emulsion formed in step 3 with 1050mL calcium carbonate, sodium alginate and carrageenan solution (the mass ratio of sodium alginate to carrageenan is 20:3, and the total mass percentage concentration is 3%, The mass percentage of calcium carbonate is 2%, the temperature is 23 °C), and extruded into a 2.5% calcium chloride solution at a temperature of 10 °C to form solidified multi-core microcapsules with a particle size of about 3 mm (Figure 1, C).

该微胶囊无粘连、成球性好、表面圆整,干酪乳杆菌菌数为1×1010cfu/mL,该微胶囊在85℃下加热处理3分钟,剩余活菌数为3.2×109cfu/mL;在25℃下密封储存60天,剩余活菌数为5.6×109cfu/mL;在人工模拟胃液下4小时,干酪乳杆菌释放量为16.3%,人工模拟肠液下4小时,干酪乳杆菌释放量为94.3%。 The microcapsules have no adhesion, good spheroidity, rounded surface, the number of Lactobacillus casei is 1×10 10 cfu/mL, the microcapsules are heat-treated at 85°C for 3 minutes, and the number of remaining viable bacteria is 3.2×10 9 cfu/mL; sealed storage at 25°C for 60 days, the number of remaining viable bacteria is 5.6×10 9 cfu/mL; 4 hours under artificial simulated gastric juice, the release of Lactobacillus casei is 16.3%, 4 hours under artificial simulated intestinal juice, The release rate of Lactobacillus casei was 94.3%.

实施例4Example 4

步骤1:将1g卡拉胶悬浮于100mL蒸馏水中,加热溶解后0.4g葡萄糖和0.2g酵母抽提物和1.8g乳酸,以氢氧化钠调节pH为4.0,并冷却到40℃。 Step 1: Suspend 1 g of carrageenan in 100 mL of distilled water, heat to dissolve 0.4 g of glucose, 0.2 g of yeast extract and 1.8 g of lactic acid, adjust the pH to 4.0 with sodium hydroxide, and cool to 40°C.

步骤2:然后在步骤1形成的溶液中加入干酪乳杆菌菌泥或干酪乳杆菌固态发酵物料,并混合均匀(混合液中干酪乳杆菌浓度为7.8×1011cfu/mL)。 Step 2: Then add Lactobacillus casei sludge or Lactobacillus casei solid-state fermentation material to the solution formed in Step 1, and mix evenly (the concentration of Lactobacillus casei in the mixed solution is 7.8×10 11 cfu/mL).

步骤3:将上述混合溶液与150mL温度为40℃的棕榈油混合,其中棕榈油中包括质量百分比含量为4%的斯潘-80,并在2000转/分钟搅拌速度下搅拌至温度下降到25℃时停止搅拌,此时即获得干酪乳杆菌水凝胶微芯乳液,微芯的平均粒径为34.2μm。 Step 3: Mix the above mixed solution with 150mL of palm oil at a temperature of 40°C, wherein the palm oil includes 4% Span-80 by mass percentage, and stir at a stirring speed of 2000 rpm until the temperature drops to 25 Stirring was stopped at ℃, and the Lactobacillus casei hydrogel micro-core emulsion was obtained at this moment, and the average particle diameter of the micro-core was 34.2 μm.

步骤4:进一步将步骤3形成的上述250mL微芯乳液与500mL碳酸钙、海藻酸钠和黄原胶溶液混合均匀(海藻酸钠与黄原胶质量比为20:3、合计质量百分比浓度为2%,碳酸钙质量百分比含量为2.5%),并挤出到温度为20℃的2%氯化钙溶液中,形成粒径约2mm的固化多芯微胶囊(图1,D)。 Step 4: Further mix the above-mentioned 250mL microcore emulsion formed in step 3 with 500mL calcium carbonate, sodium alginate and xanthan gum solution (the mass ratio of sodium alginate to xanthan gum is 20:3, and the total mass percentage concentration is 2 %, the mass percentage of calcium carbonate is 2.5%), and extruded into a 2% calcium chloride solution at a temperature of 20 °C to form solidified multi-core microcapsules with a particle size of about 2 mm (Fig. 1, D).

该微胶囊无粘连、成球性好、表面圆整,干酪乳杆菌菌数为1×1011cfu/mL,该微胶囊在85℃下加热处理3分钟,剩余活菌数为4.1×1010cfu/mL;在25℃下密封储存60天,剩余活菌数为7.2×1010cfu/mL;在人工模拟胃液下4小时,干酪乳杆菌释放量为14.7%,人工模拟肠液下4小时,干酪乳杆菌释放量为95.9%。 The microcapsules have no adhesion, good spheroidity, rounded surface, and the number of Lactobacillus casei is 1×10 11 cfu/mL. The microcapsules are heat-treated at 85°C for 3 minutes, and the number of remaining viable bacteria is 4.1×10 10 cfu/mL; sealed storage at 25°C for 60 days, the number of remaining viable bacteria is 7.2×10 10 cfu/mL; 4 hours under artificial simulated gastric juice, the release of Lactobacillus casei is 14.7%, 4 hours under artificial simulated intestinal juice, The release rate of Lactobacillus casei was 95.9%.

Claims (9)

1.一种包埋酪乳杆菌的微胶囊,其特征在于:微胶囊为三层包埋的多芯结构,其中,干酪乳杆菌菌泥或固态发酵产物被包埋于第一水凝胶包被层中形成微芯,在所述的微芯外的第二个包被层为植物油,多个携带植物油包被的微芯被包埋于由水溶性高分子材料形成的第三个包被层中,其中,所述的干酪乳杆菌菌泥或固态发酵产物为保藏号为CCTCC NO:M 2011424的干酪乳杆菌菌株BFT-1所产生。 1. A microcapsule for embedding Lactobacillus casei, characterized in that: the microcapsule is a multi-core structure embedded in three layers, wherein, Lactobacillus casei bacterium slime or solid-state fermentation product is embedded in the first hydrogel package A microcore is formed in the coating layer, and the second coating layer outside the microcore is vegetable oil, and a plurality of microcores coated with vegetable oil are embedded in a third coating formed by a water-soluble polymer material. In the layer, wherein, the said Lactobacillus casei sludge or solid-state fermentation product is produced by the Lactobacillus casei strain BFT-1 whose preservation number is CCTCC NO: M 2011424. 2.根据权利要求1所述微胶囊,其特征在于,所述的干酪乳杆菌浓度为109~1011cfu/mL。 2 . The microcapsule according to claim 1 , wherein the concentration of the Lactobacillus casei is 10 9 -10 11 cfu/mL. 3.根据权利要求1所述微胶囊,其特征在于,所述的微芯结构为水凝胶,粒径10~100μm,第二包被层包为融点为24℃的棕榈油层。 3. The microcapsule according to claim 1, characterized in that, the micro-core structure is a hydrogel with a particle size of 10-100 μm, and the second coating layer is wrapped with a palm oil layer with a melting point of 24°C. 4.根据权利要求1所述微胶囊,其特征在于,水溶性高分子材料为海藻酸钠-聚乙醇。 4. The microcapsule according to claim 1, wherein the water-soluble polymer material is sodium alginate-polyethylene glycol. 5.一种制包括干酪乳杆菌的微胶囊的方法,其特征在于,该方法包括以下步骤: 步骤1:配制pH为3.5~5.0、卡拉胶质量百分含量为0.1~2%、葡萄糖含量0.1~0.5%、酵母抽提物含量为0.1~0.5%、乳酸浓度为1~5%的混合水溶液,并将温度调节到38~45℃;然后在上述溶液中加入干酪乳杆菌菌泥或固态发酵产物,即形成干酪乳杆菌水凝胶溶液,其中,所述的干酪乳杆菌菌泥或固态发酵产物为保藏号为CCTCC NO:M 20114244的干酪乳杆菌菌株BFT-1所产生的。 5. A method for preparing microcapsules comprising Lactobacillus casei, characterized in that the method comprises the following steps: Step 1: Prepare a pH of 3.5 to 5.0, a carrageenan mass percentage of 0.1 to 2%, and a glucose content of 0.1 ~0.5%, yeast extract content of 0.1~0.5%, lactic acid concentration of 1~5% mixed aqueous solution, and adjust the temperature to 38~45°C; then add Lactobacillus casei sludge or solid-state fermentation to the above solution The product is to form a Lactobacillus casei hydrogel solution, wherein said Lactobacillus casei sludge or solid-state fermentation product is produced by the Lactobacillus casei strain BFT-1 whose preservation number is CCTCC NO: M 20114244. 6.根据权利要求5所述的方法,其特征在于,并将温度调节为40℃,干酪乳杆菌的最佳浓度是8×1010cfu/mL。 6. The method according to claim 5, characterized in that, and adjusting the temperature to 40°C, the optimum concentration of Lactobacillus casei is 8×10 10 cfu/mL. 7.根据权利要求5所述的方法,其特征在于,该方法还包括步骤2:制备外层棕榈油包被的干酪乳杆菌水凝胶微芯:将步骤1制备的所述干酪乳杆菌水凝胶溶液按体积比1:1~5与相同温度的斯潘-80混合,其中斯潘-80中包括质量百分比浓度为1~5%的棕榈油,在1000~2000转/分钟搅拌下形成乳液,然后冷却到25℃,即可形成外层棕榈油包被的干酪乳杆菌水凝胶微芯,结构特征为固态凝胶微芯。 7. The method according to claim 5, characterized in that, the method also comprises step 2: preparing the Lactobacillus casei hydrogel microcore coated with outer palm oil: the Lactobacillus casei water prepared in step 1 The gel solution is mixed with Span-80 at the same temperature at a volume ratio of 1:1~5, wherein Span-80 includes palm oil with a mass percentage concentration of 1~5%, and is formed under stirring at 1000~2000 rpm The emulsion is then cooled to 25°C to form a Lactobacillus casei hydrogel microcore coated with palm oil, and the structure is characterized by a solid gel microcore. 8.根据权利要求7所述的方法,其特征在于,该方法还包括步骤3:制备包埋干酪乳杆菌微芯的多芯微胶囊:将步骤2形成的外层棕榈油包被的干酪乳杆菌微芯乳液按体积比1:2~4与碳酸钙-海藻酸钠-黄原胶混合溶液混合均匀后,并滴入温度为0~20℃的1~4%氯化钙溶液中,半小时后形成包埋干酪乳杆菌微芯的固化多芯微胶囊,该胶囊中干酪乳杆菌微芯、棕榈油和海藻酸钠-黄原胶等均为固态结构。 8. method according to claim 7, is characterized in that, this method also comprises step 3: prepare the multi-core microcapsule of embedding Lactobacillus casei microcore: the cheese milk that the outer layer palm oil that step 2 forms is coated Bacillus micro-core emulsion is mixed with calcium carbonate-sodium alginate-xanthan gum mixed solution at a volume ratio of 1:2~4, and then dropped into 1~4% calcium chloride solution at a temperature of 0~20°C. Hours later, the solidified multi-core microcapsules embedding the Lactobacillus casei microcore are formed, and the Lactobacillus casei microcore, palm oil and sodium alginate-xanthan gum etc. are all solid structures in the capsule. 9.根据权利要求8所述的方法,其特征在于,海藻酸钠和黄原胶之间的质量比为20:1~5、海藻酸钠和黄原胶合计质量百分比浓度为1~3%,碳酸钙质量百分比含量为0.5~3%,温度为22~26℃。 9. The method according to claim 8, wherein the mass ratio between sodium alginate and xanthan gum is 20:1-5, and the total mass percentage concentration of sodium alginate and xanthan gum is 1-3% , the mass percentage of calcium carbonate is 0.5~3%, and the temperature is 22~26°C.
CN201310626099.1A 2013-11-28 2013-11-28 Lactobacillus casei embedding microcapsule and preparation method thereof Expired - Fee Related CN103652891B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310626099.1A CN103652891B (en) 2013-11-28 2013-11-28 Lactobacillus casei embedding microcapsule and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310626099.1A CN103652891B (en) 2013-11-28 2013-11-28 Lactobacillus casei embedding microcapsule and preparation method thereof

Publications (2)

Publication Number Publication Date
CN103652891A true CN103652891A (en) 2014-03-26
CN103652891B CN103652891B (en) 2015-04-08

Family

ID=50292610

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310626099.1A Expired - Fee Related CN103652891B (en) 2013-11-28 2013-11-28 Lactobacillus casei embedding microcapsule and preparation method thereof

Country Status (1)

Country Link
CN (1) CN103652891B (en)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104957254A (en) * 2015-06-08 2015-10-07 内蒙古蒙牛乳业(集团)股份有限公司 Probiotics gel particle, preparation method thereof and dairy containing probiotics gel particle
CN105595359A (en) * 2016-01-29 2016-05-25 江苏微康生物科技有限公司 Positioning and controlled-release microcapsule probiotics and preparation method thereof
CN106222158A (en) * 2016-05-30 2016-12-14 浙江工商大学 A kind of microcapsule preparation method embedding lactobacillus
CN108851155A (en) * 2018-07-11 2018-11-23 天添爱(青岛)生物科技有限公司 A kind of technique extending the diatery supplement nutrient supplement shelf-life
CN110771898A (en) * 2019-11-08 2020-02-11 厦门九和良方医药科技有限公司 Probiotic microcapsule, preparation method and application thereof
CN111134333A (en) * 2018-11-06 2020-05-12 内蒙古蒙牛乳业(集团)股份有限公司 Food or health product containing probiotic microcapsules and preparation method thereof
CN111134332A (en) * 2018-11-06 2020-05-12 内蒙古蒙牛乳业(集团)股份有限公司 Method for preparing probiotic microcapsules by fluidized bed spray granulation method and product thereof
CN111134331A (en) * 2018-11-06 2020-05-12 内蒙古蒙牛乳业(集团)股份有限公司 Probiotic microcapsule and preparation method thereof
CN111134330A (en) * 2018-11-06 2020-05-12 内蒙古蒙牛乳业(集团)股份有限公司 Method for preparing probiotic microcapsules by extrusion granulation method and product thereof
CN113440467A (en) * 2021-06-02 2021-09-28 东阿阿胶股份有限公司 Repairing and moistening hydrogel microcapsule containing donkey-hide gelatin as well as preparation method and application of repairing and moistening hydrogel microcapsule
CN113925169A (en) * 2021-11-23 2022-01-14 天津小薇生物科技有限公司 Gout-relieving probiotic composition, preparation method and application thereof
CN117210382A (en) * 2023-11-09 2023-12-12 内蒙古蒙牛乳业(集团)股份有限公司 Multilayer probiotic embedded particles and preparation method and application thereof

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1916161A (en) * 2006-09-08 2007-02-21 肖雯娟 Embedding protection method for beneficial bacteria of intestinal tract
CN101683604A (en) * 2009-08-21 2010-03-31 黑龙江大学 Method for preparing lactobacillus microcapsules
CN102595938A (en) * 2009-07-09 2012-07-18 德戈玛益生菌有限公司 Heat resistant probiotic compositions and healthy food comprising them
CN102960598A (en) * 2012-11-19 2013-03-13 陕西科技大学 Method for preparing three-layer embedded bifidobacterium microcapsules
CN103180432A (en) * 2010-08-26 2013-06-26 梅西大学 Method for preparing shelf-stable probiotic food
CN103282028A (en) * 2010-08-10 2013-09-04 R·P·舍勒科技有限责任公司 Process of manufacturing a stable softgel capsule containing microencapsulated probiotic bacteria

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1916161A (en) * 2006-09-08 2007-02-21 肖雯娟 Embedding protection method for beneficial bacteria of intestinal tract
CN102595938A (en) * 2009-07-09 2012-07-18 德戈玛益生菌有限公司 Heat resistant probiotic compositions and healthy food comprising them
CN101683604A (en) * 2009-08-21 2010-03-31 黑龙江大学 Method for preparing lactobacillus microcapsules
CN103282028A (en) * 2010-08-10 2013-09-04 R·P·舍勒科技有限责任公司 Process of manufacturing a stable softgel capsule containing microencapsulated probiotic bacteria
CN103180432A (en) * 2010-08-26 2013-06-26 梅西大学 Method for preparing shelf-stable probiotic food
CN102960598A (en) * 2012-11-19 2013-03-13 陕西科技大学 Method for preparing three-layer embedded bifidobacterium microcapsules

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
宋心远 等: "《新型染整技术》", 30 November 1999, article "微胶囊", pages: 131 *

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104957254A (en) * 2015-06-08 2015-10-07 内蒙古蒙牛乳业(集团)股份有限公司 Probiotics gel particle, preparation method thereof and dairy containing probiotics gel particle
CN104957254B (en) * 2015-06-08 2018-10-16 内蒙古蒙牛乳业(集团)股份有限公司 Probiotic gel particle, preparation method and the dairy products containing it
CN105595359A (en) * 2016-01-29 2016-05-25 江苏微康生物科技有限公司 Positioning and controlled-release microcapsule probiotics and preparation method thereof
CN106222158A (en) * 2016-05-30 2016-12-14 浙江工商大学 A kind of microcapsule preparation method embedding lactobacillus
CN106222158B (en) * 2016-05-30 2021-06-15 浙江工商大学 A kind of microcapsule preparation method of embedding lactobacillus
CN108851155A (en) * 2018-07-11 2018-11-23 天添爱(青岛)生物科技有限公司 A kind of technique extending the diatery supplement nutrient supplement shelf-life
CN111134331A (en) * 2018-11-06 2020-05-12 内蒙古蒙牛乳业(集团)股份有限公司 Probiotic microcapsule and preparation method thereof
CN111134332A (en) * 2018-11-06 2020-05-12 内蒙古蒙牛乳业(集团)股份有限公司 Method for preparing probiotic microcapsules by fluidized bed spray granulation method and product thereof
CN111134333A (en) * 2018-11-06 2020-05-12 内蒙古蒙牛乳业(集团)股份有限公司 Food or health product containing probiotic microcapsules and preparation method thereof
CN111134330A (en) * 2018-11-06 2020-05-12 内蒙古蒙牛乳业(集团)股份有限公司 Method for preparing probiotic microcapsules by extrusion granulation method and product thereof
CN111134334A (en) * 2018-11-06 2020-05-12 内蒙古蒙牛乳业(集团)股份有限公司 Probiotic microcapsule soft particles and preparation method thereof
CN111134334B (en) * 2018-11-06 2023-08-29 内蒙古蒙牛乳业(集团)股份有限公司 A kind of probiotic microcapsule soft granule and its preparation method
CN110771898A (en) * 2019-11-08 2020-02-11 厦门九和良方医药科技有限公司 Probiotic microcapsule, preparation method and application thereof
CN113440467A (en) * 2021-06-02 2021-09-28 东阿阿胶股份有限公司 Repairing and moistening hydrogel microcapsule containing donkey-hide gelatin as well as preparation method and application of repairing and moistening hydrogel microcapsule
CN113440467B (en) * 2021-06-02 2022-07-05 东阿阿胶股份有限公司 Repairing and moistening hydrogel microcapsule containing donkey-hide gelatin as well as preparation method and application of repairing and moistening hydrogel microcapsule
CN113925169A (en) * 2021-11-23 2022-01-14 天津小薇生物科技有限公司 Gout-relieving probiotic composition, preparation method and application thereof
CN117210382A (en) * 2023-11-09 2023-12-12 内蒙古蒙牛乳业(集团)股份有限公司 Multilayer probiotic embedded particles and preparation method and application thereof
CN117210382B (en) * 2023-11-09 2024-01-30 内蒙古蒙牛乳业(集团)股份有限公司 Multilayer probiotic embedded particles and preparation method and application thereof

Also Published As

Publication number Publication date
CN103652891B (en) 2015-04-08

Similar Documents

Publication Publication Date Title
CN103652891B (en) Lactobacillus casei embedding microcapsule and preparation method thereof
Shi et al. Encapsulation of probiotic Lactobacillus bulgaricus in alginate–milk microspheres and evaluation of the survival in simulated gastrointestinal conditions
Shi et al. Encapsulation of Lactobacillus bulgaricus in carrageenan-locust bean gum coated milk microspheres with double layer structure
JP6081374B2 (en) Protection of microbial cells from acid degradation
Silva et al. Symbiotic microencapsulation to enhance Lactobacillus acidophilus survival
Rosas‐Ledesma et al. Calcium alginate capsules for oral administration of fish probiotic bacteria: assessment of optimal conditions for encapsulation
Li et al. Construction of multilayer alginate hydrogel beads for oral delivery of probiotics cells
CN105310080B (en) Probiotic microcapsules and its preparation method and application
Islam et al. Microencapsulation of live probiotic bacteria
CN104435283B (en) A kind of probiotic microcapsule and preparation method added with prebiotics
CN103932186B (en) A kind of bifidus longum bb microcapsule and preparation method thereof
CN107260704B (en) Enterococcus faecalis microcapsule and preparation method thereof
CN101289648B (en) Enterococcus faecium microcapsule formulation and method for preparing same
Lai et al. Microencapsulation of Lactobacillus rhamnosus GG with flaxseed mucilage using co-extrusion technique
Vivek Use of encapsulated probiotics in dairy based foods
Mandal et al. Enhancement of survival of alginate‐encapsulated Lactobacillus casei NCDC 298
CN112956698A (en) Probiotics microcapsule embedded blasting bead and preparation method thereof
CN106617093B (en) Acid-resistant and stable probiotic microcapsule and preparation method and application thereof
CN104388416A (en) Preparation method of microporous starch embedded lactic acid bacteria
CN109007807A (en) A kind of microcapsules fruit ferment powder and preparation method thereof
CN113040174A (en) Microcapsule microbial inoculum and preparation method and application thereof
Panghal et al. Microencapsulation for delivery of probiotic bacteria
CN112335884A (en) Novel probiotic microsphere and preparation method thereof
Krasaekoopt Microencapsulation of probiotics in hydrocolloid gel matrices: a review
Li et al. Preparation and property of layer-by-layer alginate hydrogel beads based on multi-phase emulsion technique

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20150408

Termination date: 20211128